Skip to main content

Lawrence Simeon Barak

Associate Research Professor of Cell Biology
Cell Biology
Duke Box 3287, Durham, NC 27710
483 Clin & Res Labs, Durham, NC 27710

Selected Grants


Developing non-opiate GPCR signaling biased agents for pain management

ResearchCo Investigator · Awarded by Department of Defense · 2022 - 2026

Development of SBI-553, an allosteric modulator of NTR1, for the treatment of substance use disorders

ResearchPrincipal Investigator · Awarded by Sanford Burnham Prebys Medical Discovery Institute · 2023 - 2025

Development of arrestin-biased dopamine D1 receptor (D1R) ligand for the treatment of Parkinson's disease with minimal L-DOPA induced dyskinesia

ResearchPrincipal Investigator · Awarded by Michael J. Fox Foundation for Parkinson's Research · 2023 - 2024

Exploiting Biased Agonism at the Ghrelin Receptor (GHSR 1a) for Opioid Addiction

FellowshipCo-Sponsor · Awarded by National Institutes of Health · 2022 - 2023

Development of SBI-553, an allosteric modulator of NTR1, for the treatment of substance use disorders

ResearchCo-Principal Investigator · Awarded by Sanford Burnham Prebys Medical Discovery Institute · 2019 - 2022

Developing non-opiate GPCR signaling biased agents for pain management

ResearchCo Investigator · Awarded by Department of Defense · 2022 - 2026

Development of SBI-553, an allosteric modulator of NTR1, for the treatment of substance use disorders

ResearchPrincipal Investigator · Awarded by Sanford Burnham Prebys Medical Discovery Institute · 2023 - 2025

Development of arrestin-biased dopamine D1 receptor (D1R) ligand for the treatment of Parkinson's disease with minimal L-DOPA induced dyskinesia

ResearchPrincipal Investigator · Awarded by Michael J. Fox Foundation for Parkinson's Research · 2023 - 2024

Exploiting Biased Agonism at the Ghrelin Receptor (GHSR 1a) for Opioid Addiction

FellowshipCo-Sponsor · Awarded by National Institutes of Health · 2022 - 2023

Development of SBI-553, an allosteric modulator of NTR1, for the treatment of substance use disorders

ResearchCo-Principal Investigator · Awarded by Sanford Burnham Prebys Medical Discovery Institute · 2019 - 2022

Managing L-­DOPA Induced Dyskinesias by Targeting Dopamine D1 Receptor Biased Signaling

ResearchCo Investigator · Awarded by Michael J. Fox Foundation for Parkinson's Research · 2019 - 2022

Leveraging Functional Selectivity in the Neurotensin Receptor 1-Mediated Treatment of Addiction

ResearchCo-Mentor · Awarded by National Institutes of Health · 2019 - 2021

Establishing the molecular and cellular mechanisms of Lgr5 signaling for controlling cancer stem cell behavior

ResearchCollaborator · Awarded by National Institutes of Health · 2017 - 2021

Akt/GSK-3 Signaling Cascade and the Actions of Dopamine

ResearchCo Investigator · Awarded by National Institutes of Health · 2005 - 2020

Inhibition of Wnt/B-Catenin Signaling in Colorectal Cancer Therapy

ResearchCo Investigator · Awarded by National Institutes of Health · 2013 - 2019

Biased Agonism at Neurotensin Receptor 1 for the Treatment of Methamphetamine Addiction

FellowshipCo-Sponsor · Awarded by National Institutes of Health · 2017 - 2019

Drug Abuse: Discovering Ligands for Pertinent GPCRs

ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2010 - 2019

A Cancer Rainbow Mouse for Simultaneous Assessment of Multiple Oncogenes

ResearchCo Investigator · Awarded by National Institutes of Health · 2015 - 2018

Screening and identification of beta-arrestin biased dopamine receptor ligands for PD symptom therapy.

ResearchConsultant · Awarded by Michael J. Fox Foundation for Parkinson's Research · 2016 - 2016

Beta-arrestin Regulation of Ghrelin Signaling in Modulating Addictive Behavior

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2014 - 2016

Novel high-throughput screening for modifiers of TorsinA pathology

ResearchCollaborator · Awarded by National Institutes of Health · 2013 - 2015

A Cancer Rainbow Mouse for the Simultaneous Assessment of Multiple Oncogenes

ResearchCo Investigator · Awarded by National Institutes of Health · 2012 - 2015

Discovering Ligands for a5-a3-b4 Nicotinic Acetylcholine Receptors.

ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2010 - 2014

Small molecule screen to enhance epithelial repair

ResearchCo Investigator · Awarded by National Institutes of Health · 2011 - 2012

Small Molecule Agonsists for the Neurotensin 1 Receptor

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2009 - 2012

Drug Abuse: Discovering Ligands for Pertinent GPCRs

ResearchCo Investigator · Awarded by National Institutes of Health · 2006 - 2010

Innovative Assays for Oncogenic Hedgehog Signaling

ResearchCo Investigator · Awarded by National Institutes of Health · 2006 - 2010

Dopamine Receptors: Characterization And Regulation

ResearchAssistant Research Professor · Awarded by National Institutes of Health · 1983 - 2008

Molecular fingerprinting of GPCR ligands in Cancer

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2004 - 2006

Zeiss LSM510 META confocal-fluorescence spectroscopy

EquipmentDirector · Awarded by National Institutes of Health · 2003 - 2004

Same

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1999 - 2004

Mechanisms Of Beta2-Adrenergic Receptor Internalization

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1996 - 1999